Axiom Insilico is a biotechnology company specializing in artificial intelligence, bioinformatics, and biostatistics applied to biomedical research. We develop predictive models for precision medicine, identify therapeutic targets, and advance AI-driven drug discovery. We also provide clinical trial design, statistical analysis, clinical data management, and omics data analysis services. We collaborate with biotech and pharmaceutical companies, CROs, and research institutions to transform complex data into innovative scientific and clinical solutions.
Rubén Aladid
CEO
